As reported on Science Daily, a new preclinical study has revealed an unexpected link between nutrition and cancer treatment, with researchers finding that some diets commonly associated with weight gain…
Some infections can raise a person’s risk of developing cancer. As reported on MedPage Today, global analysis estimates that about 2.3 million new cancer cases in 2024—roughly 12% of all…
As reported on Medical Daily, Artiva Biotherapeutics has discontinued development of its investigational autoimmune cell therapy, AlloNK, after two participant deaths occurred during a mid-stage clinical study. The San Diego-based…
As reported by Science Daily, Researchers at Johns Hopkins have uncovered a long-sought explanation for how a toxin-producing gut bacterium contributes to colorectal cancer, identifying a cellular receptor that allows…
Editor's Note: This article was written and submitted to us by Pamela Mason, Patient Speaker & Advocate. Sometimes, the hardest part of a medical appointment begins days before I walk…
Changes in a group of genes called BAF may help cancer cells grow by altering how DNA is folded and which genes are switched on. As reported by SciTechDaily, a…
As reported on PharmaTimes, Merz Therapeutics has announced the completion of participant enrollment in two international Phase 3 clinical trials investigating XEOMIN (incobotulinumtoxinA) as a potential preventive treatment for both…
AML is an aggressive cancer of the blood and bone marrow, that sometimes moves so quickly, that treatment cannot conquer it. Car-T cell therapy has been incredibly successful in B-cell…
Editor's Note: This article was written and submitted to us by Victoria Barghout, CEO and Founder Viver Health. Sixteen years ago, I was diagnosed with breast cancer the day before…
As reported on ScienceDaily, researchers at the University of Virginia (UVA) have developed an experimental treatment strategy that could address two of the biggest challenges in glioblastoma care: targeting the…
Editor's Note: This article was written by Wayne Eskridge, founder of the Fatty Liver Foundation. When we are diagnosed with F4 MASH (cirrhosis) we are often told that it is…
Editor's Note: This story was submitted to Patient Worthy by Roger Templeman, Executive Director of Stabilize Revitalize Fort Pierce (SRFP), a grassroots nonprofit in Fort Pierce, Florida. Last year in…
According to recent international studies reported by MedicalXpress, the drug sac-TMT (sacituzumab tirumotecan) has been found to reduce recurrence or death from endometrial cancer. The Process After attaching to proteins…
Calcinosis remains one of the most difficult complications to manage in patients with dermatomyositis (DM) and juvenile dermatomyositis (JDM), often causing pain, disability, and reduced quality of life. New findings…
People often tell me how positive I am, and for the most part, I think that’s true. But after living with dystonia for more than two decades, my understanding of…
As reported by the Manila Times, the FDA has formally accepted uniQure’s biologics license application for ifezuntirgene inilparvovec (AMT-130), an experimental gene therapy being developed for people living with Huntington’s…
My name is Jonathan Eskenas and I live in Los Angeles with my wife and our dogs. I'm an executive producer of television series and movies with dozens of credits,…
As reported on PharmaBiz, a major UK breast cancer study has passed a significant recruitment milestone, with more than 1,000 patients now participating in research that could dramatically reduce the…
In a collaborative effort between University College Institute (UCL) and the University of Cambridge, researchers have engineered personalized computational frameworks—often termed tumor "digital twins"—to forecast therapeutic responses and overcome drug…
As published in Sage Journals, researchers have developed an accessible, machine learning-driven histopathology workflow that enables quantitative evaluation of metabolic dysfunction-associated steatohepatitis (MASH) in laboratory mice without requiring coding expertise…
The Genomics England Research Study listed approximately two hundred rare treatable conditions of children five years old or younger. Genomics has had, and continues to have, an impact on healthcare.…
My name is Sami Yusuf Baker. I am 19 years old, and I live in a small village in the Kurdistan Region of Iraq. I was born with ichthyosis, a…
My name is Rim Wafaa Bendjaada. I am 22 years old, a rare disease and pulmonary hypertension advocate from Algeria, living with pulmonary veno-occlusive disease (PVOD), a rare and complex…
Editor's Note: The following is an excerpt from Bird’s Eye View: Stories of a Life Lived in Health Care by Sue Robins. I remember every single act of kindness I’ve encountered…
As reported on Bioengineer and ScienMag, a new spatial transcriptomics study has provided fresh insight into how different regions of the liver are remodeled during metabolic dysfunction-associated steatohepatitis (MASH). By…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
